Keeping up with the science: Innovation in the health and care system post Brexit
Article
Innovation in health – new treatments, technologies and processes – can help drive improvements in healthcare and ultimately health outcomes. We are on the cusp of a new wave of innovation driven by robotics, big data and therapeutic breakthroughs such as cell and gene therapy.
However, the history of innovation in the UK shows that the health and care system is often slow to adopt new technologies. The government has tried to address the causes of this problem, most recently through the Accelerated Access Review (AAR) and Life Sciences (Industrial) Strategy.
Although these initiatives offer a number of sensible policy suggestions, the reality is that they will fail to deliver on their potential without a Brexit deal that prioritises health and care; a new long-term funding settlement for health and care; and a clear plan for system reform in the NHS.
Related items

In search of the Scottish economy's 'low-hanging fruit': IPPR Scotland responds to the Muscatelli report
The report is a serious and thoughtful analysis of what is and isn’t working in Scotland’s economic development eco-system.
Celebrating 10 years of IPPR Scotland
In celebration of our 10th anniversary, IPPR Scotland was delighted to host a daylong conference on October 29.
A war on bills: Why the government should focus relentlessly on the cost of living
The public’s top concern is the cost of living.